An mRNA Vaccine against SARS-CoV-2 — Preliminary Report | Zendy

Lisa A. Jackson | Zendy; Evan J. Anderson | Zendy; Nadine Rouphael | Zendy; Paul C. Roberts | Zendy; Mamodikoe Makhene | Zendy; Rhea N. Coler | Zendy; Michele Paine McCullough | Zendy; James D. Chappell | Zendy; Mark R. Denison | Zendy; Laura J. Stevens | Zendy; Andrea J. Pruijssers | Zendy; Adrian B. McDermott | Zendy; Britta Flach | Zendy; Nicole A. DoriaRose | Zendy; Kizzmekia S. Corbett | Zendy; Kaitlyn M. Morabito | Zendy; Sijy O’Dell | Zendy; Stephen D. Schmidt | Zendy; Phillip A. Swanson | Zendy; Marcelino Padilla | Zendy; John R. Mascola | Zendy; Kathleen M. Neuzil | Zendy; Hamilton Bennett | Zendy; Wellington Sun | Zendy; Etza Peters | Zendy; Mat Makowski | Zendy; Jim Albert | Zendy; Kaitlyn Cross | Zendy; Wendy Buchanan | Zendy; Rhonda Pikaart-Tautges | Zendy; Julie E. Ledgerwood | Zendy; Barney S. Graham | Zendy; John H. Beigel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Author(s) -

Lisa A. Jackson,

Evan J. Anderson,

Nadine Rouphael,

Paul C. Roberts,

Mamodikoe Makhene,

Rhea N. Coler,

Michele Paine McCullough,

James D. Chappell,

Mark R. Denison,

Laura J. Stevens,

Andrea J. Pruijssers,

Adrian B. McDermott,

Britta Flach,

Nicole A. DoriaRose,

Kizzmekia S. Corbett,

Kaitlyn M. Morabito,

Sijy O’Dell,

Stephen D. Schmidt,

Phillip A. Swanson,

Marcelino Padilla,

John R. Mascola,

Kathleen M. Neuzil,

Hamilton Bennett,

Wellington Sun,

Etza Peters,

Mat Makowski,

Jim Albert,

Kaitlyn Cross,

Wendy Buchanan,

Rhonda Pikaart-Tautges,

Julie E. Ledgerwood,

Barney S. Graham,

John H. Beigel

Publication year - 2020

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2022483

Subject(s) - virology , covid-19 , medicine , outbreak , infectious disease (medical specialty) , disease

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized prefusion SARS-CoV-2 spike protein.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research